The CDMO Story: Indian Pharma's Next Big Growth Phase
Raghav Behani
February 09, 2025
The U.S. BIOSECURE Act aims to reduce U.S. reliance on Chinese biotechnology firms by 2032. The bill would have banned U.S. executive agenci...
9 February 2025
6 December 2024
I am back
Raghav Behani
December 06, 2024
Hello readers, I am back. Will start posting on equities again. Do put in your email on the newsletter button to get email alerts whenever t...
1 August 2022
How are gold coins priced?
Raghav Behani
August 01, 2022
Ever wondered why gold coins are expensive compared to the price of gold on the MCX? Typically, the spot price of a commodity is lower than ...
2 July 2022
Term insurance: Limited pay vs Regular pay
Raghav Behani
July 02, 2022
While comparing a 3 Crore term insurance cover for a 28 year old till the age of 85, I see that there is an option to pay a Rs 1,54,000 prem...
14 June 2022
How XIRR and CAGR can mislead
Raghav Behani
June 14, 2022
XIRR and CAGR are fancy terms which ultimately tell you how much returns you are making on your investment. XIRR is used for SIPs or invest...
18 December 2021
Grip Invest: 22% IRR - Review
Raghav Behani
December 18, 2021
TLDR: The pre-tax IRR of 22% translates to a post-tax IRR of 11% and is comparable to a return of 7.6% p.a. post tax. This investment is ris...
14 December 2021
Power Grid Corporation of India - Fundamental Analysis
Raghav Behani
December 14, 2021
In this post, we will study the business model of Power Grid Corporation of India and try to analyze what the stock price is worth as per ac...
